Aspen Ideas Festival is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. They are better corroborated than the beat average, carrying 9 original sources each against 4.7 for the same window. That works out to roughly 0.7 stories per week across a 21-day span.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about National Institutes of Health
Aspen Ideas Festival is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. They are better corroborated than the beat average, carrying 9 original sources each against 4.7 for the same window. That works out to roughly 0.7 stories per week across a 21-day span. The 5 average consequence score is below the beat benchmark of 6.5 in the same window. funding accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. This profile follows 2 Biotech stories mentioning National Institutes of Health across the period from July 12, 2026 to August 1, 2026.
Stories tracked
2
Per week
0.7
Sources per story
9
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 121 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering National Institutes of Health. Shared-story counts are live from our verified record — not editorial picks.
Biotech and pharma firms face a growing brain drain as three top U.S. cognitive scientists relocate to the U.K. amid NIH and NSF funding upheavals. A survey shows 75% of scientists are considering leaving, threatening the talent pipeline for drug discovery and clinical research.
The transient global amnesia episode experienced by Katie Couric spotlights a rare condition with no targeted therapy, exposing a gap in CNS drug pipelines. The condition’s links to migraines and stress suggest repurposing opportunities, but market size and clinical trial hurdles remain obstacles.
National Institutes of Health is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.